Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
More than half of patients with opioid use disorder for chronic non-cancer pain (CNCP) reduced their dose through a progressive opioid withdrawal supported by a rotation to buprenorphine and/or tramadol. The aim of this research is to analyse the long-term effectiveness of opioid deprescription taki...
Saved in:
| Main Authors: | Muriel Javier, Escorial Mónica, Margarit César, Barrachina Jordi, Carvajal Cristian, Morales Domingo, Peiró Ana M. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2023-06-01
|
| Series: | Acta Pharmaceutica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/acph-2023-0018 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Realities of opioid and gabapentinoid deprescribing in socioeconomically disadvantaged communities: a qualitative evaluation
by: Charlotte L Parbery-Clark, et al.
Published: (2025-04-01) -
Stabilization of remission in patients with opioid depen dence: pharmacological and pharmacogenetic aspects
by: V. Ya. Palatkin, et al.
Published: (2016-12-01) -
Variability of response to pharmacotherapy of naltrexone and guanfacin in patients with opioid dependence syndrome: pharmacogenetic aspect
by: V. Ya Palatkin, et al.
Published: (2019-12-01) -
D.I.Ri.M.O. project: deprescription, inappropriateness evaluation and therapeutic reconciliation in hospital medicine
by: Maria Giulia Pollice, et al.
Published: (2025-03-01) -
Pharmacogenetic aspects of the efficacy of nonsteroidal anti-inflammatory drugs and opioid analgesics for postoperative pain relief after total joint arthroplasty
by: A. S. Zhiryakova, et al.
Published: (2025-06-01)